Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Cory PeruginoEmma L CulverArezou KhosroshahiWen ZhangEmanuel Della-TorreKazuichi OkazakiYoshiya TanakaMatthias LöhrNicolas SchleinitzJudith FalloonDewei SheDaniel CimboraJohn H StonePublished in: Rheumatology and therapy (2023)
NCT04540497.
Keyphrases